These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1698877)

  • 1. A sensitive two-site sandwich enzyme immunoassay for human angiotensin converting enzyme utilizing monoclonal antibodies.
    Stevens J; Danilov S; Fanburg BL; Lanzillo JJ
    J Immunol Methods; 1990 Sep; 132(2):263-73. PubMed ID: 1698877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.
    Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA
    Hypertension; 1988 Mar; 11(3):230-8. PubMed ID: 2832327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin-converting enzyme inhibitors as neutralizers of hydroxyl radical].
    Mira ML; Silva MM; Queirós MJ; Manso C
    Rev Port Cardiol; 1992 May; 11(5):425-30. PubMed ID: 1325814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterization of rat monoclonal antibodies to denatured mouse angiotensin-converting enzyme.
    Balyasnikova IV; Metzger R; Sun ZL; Berestetskaya YV; Albrecht RF; Danilov SM
    Tissue Antigens; 2005 Mar; 65(3):240-51. PubMed ID: 15730516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of monoclonal antibodies to rat lung angiotensin-converting enzyme.
    Moore MG; Chrzanowski RR; McCormick JR; Cieplinski W; Schwink A
    Clin Immunol Immunopathol; 1984 Dec; 33(3):301-12. PubMed ID: 6209045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of angiotensin converting enzyme by [3H]captopril binding.
    Strittmatter SM; Snyder SH
    Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of angiotensin converting enzyme inhibitors. A review.
    Nelson EB; Pool JL; Taylor AA
    Am J Med; 1986 Oct; 81(4C):13-8. PubMed ID: 3022580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors. Disparities in the mechanism of their antihypertensive effect.
    Garavaglia GE; Messerli FH; Nunez BD; Schmieder RE; Frohlich ED
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):214S-216S. PubMed ID: 2843195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of angiotensin-converting enzyme in canine testis.
    Sabeur K; Vo AT; Ball BA
    Reproduction; 2001 Jul; 122(1):139-46. PubMed ID: 11425338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of some pharmacokinetic parameters of 5 angiotensin-converting enzyme inhibitors in normal beagles.
    Hamlin RL; Nakayama T
    J Vet Intern Med; 1998; 12(2):93-5. PubMed ID: 9560765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a synchronous enzyme-reaction system for a highly sensitive enzyme immunoassay.
    Inouye K; Ueno I; Yokoyama S; Sakaki T
    J Biochem; 2002 Jan; 131(1):97-105. PubMed ID: 11754740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
    Essig J; Belz GG; Wellstein A
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
    Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V
    Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A deeply recessed active site in angiotensin-converting enzyme is indicated from the binding characteristics of biotin-spacer-inhibitor reagents.
    Bernstein KE; Welsh SL; Inman JK
    Biochem Biophys Res Commun; 1990 Feb; 167(1):310-6. PubMed ID: 2155615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
    Banks RJ; Mozley L; Dourish CT
    Neuroscience; 1994 Feb; 58(4):799-805. PubMed ID: 8190257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.